肝脏 ›› 2025, Vol. 30 ›› Issue (12): 1691-1694.

• 肝纤维化及肝硬化 • 上一篇    下一篇

甲苯磺酸瑞马唑仑在老年肝硬化患者全麻内镜下静脉曲张套扎术中的应用价值

李照刚, 龚政军   

  1. 614000 乐山 乐山市人民医院
  • 收稿日期:2025-05-07 发布日期:2026-02-10
  • 基金资助:
    四川省中医药信息学会科研课题(20210103)

The value of remazolam mesylate in endoscopic varicose vein ligation under general anesthesia in elderly patients with liver cirrhosis

LI Zhao-gang, GONG Zheng-jun   

  1. Leshan People's Hospital, Leshan 614000, China
  • Received:2025-05-07 Published:2026-02-10

摘要: 目的 观察甲苯磺酸瑞马唑仑在老年肝硬化患者全麻内镜下静脉曲张套扎术中的应用价值。方法 选取2022年1月至2024年12月在我院接受全麻内镜下静脉曲张套扎术治疗的老年肝硬化患者160例,采用随机数字表分为对照组(n=80,使用丙泊酚)与观察组(n=80,使用甲苯磺酸瑞马唑仑)。比较两组血流动力学参数、手术时间、麻醉恢复情况、血管活性药物使用率、累计术后认知功能障碍(POCD)发生率、不良反应发生率差异。结果 两组术前(T0)时血流动力学比较差异均无统计学意义(P>0.05)。两组术中最低值(T1)时平均动脉压(MAP)、心率(HR)均较T0时降低,但观察组T1时MAP及HR高于对照组(P<0.05)。两组T1、术后即刻(T2)时血氧饱和度(SpO2)均较T0时升高,但两组组间比较差异均无统计学意义(P>0.05)。两组T2时MAP、HR与T0时以及T1时组间比较差异均无统计学意义(P>0.05)。观察组意识恢复时间(4.21±1.29)min、PACU停留时间(12.33±3.16)min短于对照组,术后5 d累计POCD发生率(5.00%)低于对照组(P<0.05),观察组手术时间、血管活性药物使用率、术后1 d及术后3 d累计POCD发生率与对照组比较,差异均无统计学意义(P>0.05)。观察组不良反应发生率与对照组比较,差异均无统计学意义(P>0.05)。结论 甲苯磺酸瑞马唑仑用于全麻内镜下静脉曲张套扎术中可稳定血流动力学,促进患者苏醒,减少术后POCD的发生。

关键词: 甲苯磺酸瑞马唑仑, 内镜下静脉曲张套扎术, 肝硬化, 血流动力学, 认知功能障碍

Abstract: Objective Observation of the value of remazolam mesylate in endoscopic varicose vein ligation under general anesthesia in elderly patients with cirrhosis. Methods 160 cases of elderly cirrhotic patients who underwent endoscopic varicose vein ligation under general anesthesia in our hospital from January 2022 to December 2024 were selected and divided into two groups using a random number table. The control group was given propofol anesthesia induction and maintenance, and the observation group was given remazolam mesylate anesthesia induction and maintenance. Differences in hemodynamic parameters, operative time, anesthetic recovery time, vasoactive drug use rate, cumulative postoperative cognitive dysfunction (POCD) incidence, and incidence of adverse reactions were compared between the two groups. Results There was no difference in hemodynamic comparison between the two groups at preoperative (T0) (P>0.05). Mean arterial pressure (MAP) and heart rate (HR) were lower at intraoperative nadir (T1) than at T0 in both groups, but were higher at T1 in the observation group than in the control group (P<0.05). Blood oxygen saturation (SpO2) at T1 and immediate postoperative (T2) was higher than at T0 in both groups, but there was no difference between the two groups (P>0.05). There was no difference between the two groups in MAP and HR at T2 compared to T0 within each group, and no significant difference between the two groups at T2 (P>0.05). The recovery time of consciousness (4.21±1.29) min and PACU stay (12.33±3.16) min in the observation group were shorter than those in the control group, and the cumulative POCD incidence rate in the 5d postoperative period (5.00%) was lower than that in the control group (P<0.05), and the operative time, the rate of use of vasoactive drugs, and the cumulative POCD incidence rate in the observation group in the 1d postoperative period and 3d postoperative period compared with those in the control group(P>0.05). There was no difference in the incidence of adverse reactions between the observation group and the control group (P>0.05). Conclusion The use of remazolam mesylate in general anesthesia for endoscopic varicose vein ligation stabilizes intraoperative hemodynamics, promotes awakening, and reduces postoperative POCD in elderly cirrhotic patients.

Key words: Remazolam mesylate, Endoscopic varicose vein ligation, Cirrhosis, Hemodynamics, Cognitive dysfunction